Thus, in this work, the most important goal was to detect in silico compounds stabilizing the molecular complex KRas4B-PDE6δ, as well as to evaluate the antineoplastic properties of these compounds on the pancreatic cancer MIA PaCa-2 cell line, for the first time. The gene discussed is KRAS; the disease is pancreatic neoplasm.